McKesson Corporation Common Stock · Transaction Jul 8, 2026 · Filed Jul 12, 2026 · $1,001 to $15,000
McKesson Corp
Follow $MCK
One email when a member of Congress discloses a trade in it, with the official filing receipt linked.
Free. No account. Unsubscribe in one click.
Follow $MCK by emailVeridion Score
BETAMEDIUM CONF · 6 of 6 factors measuredHighest qualified requires a score of at least 75 and high confidence, including full factor coverage. Upper range can hold a higher score with lower confidence.
Composite intelligence score across six company factor categories. Missing inputs are excluded from the active factor subset.
- · Factor breakdown with raw signals
- · Day-over-day delta + driver
- · Factor coverage readout
- · Valuation · hype · market flow
- · Pro Chart event markers
- · Score history + alerts
Why is MCK moving today?
McKesson is one of three leading pharmaceutical wholesalers in the US engaged in sourcing and distributing branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospitals networks, and healthcare providers. Along with Cencora and Cardinal Health, the three account for over 90% of the US pharmaceutical wholesale industry. Outside the US market, McKesson engages in pharmaceutical wholesale and distribution in Canada. Additionally, the company supplies medical-surgical products and equipment to healthcare facilities and provides a variety of technology solutions for pharmacies.
Reported fields plus Veridion-computed history. Unsourced tiles are omitted.
MCK overview
Related filings and maps
Congress activity in MCK
MCK · Transaction Jul 8, 2026 · Filed Jul 12, 2026 · $1,001 to $15,000
McKesson Corporation Common Stock · Transaction Jun 15, 2026 · Filed Jul 15, 2026 · $1,001 to $15,000
MCK · Transaction Apr 8, 2026 · Filed May 1, 2026 · $1,001 to $15,000
McKesson Corporation Common Stock · Transaction Apr 8, 2026 · Filed May 1, 2026 · $1,001 to $15,000
MCK contract awards, year to date.
Public federal awards linked to this ticker.
PHARMACEUTICAL SUPPLIES, PHARMACY PRIME VENDOR (IDIQ) PURCHASES FOR NSSC CUSTOMERS.
BIKTARVY #376-0550 6624 BOTTLES
MCKESSON: NON-CONTROLLED MEDICATION DOS: AUGUST 10, 2026- SEPTEMBER 30, 2026
PHARMACEUTICALS
THIS CONTRACT IS TO RATIFY AN UNAUTHORIZED COMMITMENT FOR PHARMACEUTICALS FOR THE ICE...
MCK lobbying filings, year to date.
Registered lobbying filings matched to McKesson Corp.